ABVC BioPharma, Inc. Proceeds from Issuance of Other Long-term Debt
ABVC BioPharma, Inc. (ABVC) reported Proceeds from Issuance of Other Long-term Debt of $236.50 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt · last filed 2022-03-31
- ABVC BioPharma, Inc. proceeds from issuance of other long-term debt for the quarter ending 2021-12-31 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of other long-term debt for the quarter ending 2021-09-30 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of other long-term debt for the quarter ending 2021-06-30 was $0.00.
- ABVC BioPharma, Inc. proceeds from issuance of other long-term debt for the quarter ending 2021-03-31 was $236.50K.
- ABVC BioPharma, Inc. proceeds from issuance of other long-term debt for fiscal 2021 was $236.50K, a 90.11% increase from fiscal 2020.
- ABVC BioPharma, Inc. proceeds from issuance of other long-term debt for fiscal 2020 was $124.40K.
| Period end | Proceeds from Issuance of Other Long-term Debt 3 month | Proceeds from Issuance of Other Long-term Debt 6 month | Proceeds from Issuance of Other Long-term Debt 9 month | Proceeds from Issuance of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $236.50K 10-K · filed 2022-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 derived: sum of 2 quarters · filed 2021-11-15 | $236.50K 10-Q · filed 2021-11-15 | $236.50K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $236.50K 10-Q · filed 2021-08-12 | $236.50K derived: sum of 3 quarters · filed 2022-03-31 | $236.50K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $236.50K 10-Q · filed 2021-05-10 | $236.50K derived: sum of 2 quarters · filed 2022-03-31 | $236.50K derived: sum of 3 quarters · filed 2022-03-31 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $124.40K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $124.40K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $124.40K 10-Q · filed 2021-08-12 |